0800 Immune

0800 466 863

Report

COOL Project: Stakeholder summary report & chilly bin packing protocol for off-site immunisations

The purpose of the COOL Project was to investigate, review, select and test equipment used for mobile/offsite immunisations. This report explains how School-Based Immunisation Programmes are managing the cold chain and provides information and results from tests of currrent and alternative cold chain equipment and processes. The packing protocol details best practice guidelines arising from the products tested as part of the COOL Project.

Engagement of private/nongovernmental health providers in immunization service delivery: Consideration for National Immunization Programmes

WHO Guidance Note

Overall recommendations: National immunization programmes should optimize collaboration and communication with nongovernmental providers regardless of the relative contribution of nongovernmental providers to theh deliverly of vaccination.

Pertussis control strategies 2015: A consistent approach for New Zealand

In April 2015 the Ministry of Health held a Workshop at the University of Auckland to bring together expertise and those with experience from this epidemic to discuss pertussis disease control strategies and a consistent approach for New Zealand. Gains have been made in the infant primary immunisation series, but pertussis is still a major public health issue. The Ministry of Health wanted to assess the available data and strategies with the aim of minimising the impact of future outbreaks on those most vulnerable.

Mortality and morbidity of pertussis in children and young people in New Zealand.

Prepared by the Health Quality & Safety Commission for the Child and Youth Mortality Review Committee, the report emphasises the need for existing immunisation programmes to reduce the risk of pertussis in infants, especially those who are Maori, Pacific or under 3 months of age.

Childhood immunization schedule and safety: Stakeholder concerns, scientific evidence and future studies

Following on from the Adverse effects of vaccines: Evidence and causality report, the Institute of Medicine was tasked, by the Department of Health and Human Services in the U.S., to convene a committee of experts to identify scientific findings and stakeholder concerns about the safety of the current U.S. childhood immunisation schedule and identify research approaches, methodologies, and study designs that could inform this question.

Adverse effects of vaccines: Evidence and causality

In 2009 the Institute of Medicine was tasked, by the Health Resources and Services Administration in the U.S., to convene a committee of experts to review the epidemiologic, clinical, and biological evidence regarding adverse health events associated with specific vaccines including varicella zoster vaccine; influenza vaccines; hepatitis B vaccine; human papillomavirus vaccine (HPV); tetanus toxoid-containing vaccines other than those containing the whole cell pertussis component; measles, mumps, and rubella vaccines; hepatitis A vaccine; and meningococcal vaccines.